Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease

Table 3 Cardiac event rate, n (%)

Clinical event	12-mo (n = 500)	3-yr (n = 500)	5-yr (n = 500)
TLF	0 (0)	0 (0)	0 (0)
Cardiovascular Death	0 (0)	0 (0)	0 (0)
TV-MI	1 (0.2)	0 (0)	1 (0.2)
Clinically-driven TLR	0 (0)	0 (0)	0 (0)
Late ST	2 (0.4)	0 (0)	0 (0)
TVF	0 (0)	0 (0)	0 (0)
TVR	0 (0)	0 (0)	0 (0)
Very late ST	0 (0)	2 (0.4)	0 (0)
Total MACE	1 (0.2)	0 (0)	1 (0.2)

MACE: Major adverse cardiac event; TLF: Target lesion failure; TV-MI: Target vessel myocardial infarction; TLR: Target lesion revascularization; ST: Stent thrombosis; TVF: Target vessel failure; TVR: Target vessel revascularization.